509 related articles for article (PubMed ID: 15721356)
1. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection.
Trottier MD; Palian BM; Reiss CS
Virology; 2005 Mar; 333(2):215-25. PubMed ID: 15721356
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of interferon action. Interferon alpha inhibits vesicular stomatitis virus primary transcript accumulation in P1/eIF-2 alpha protein kinase-deficient human fibroblast cells.
Zhang XT; Samuel CE
J Biol Regul Homeost Agents; 1987; 1(4):157-65. PubMed ID: 2845723
[TBL] [Abstract][Full Text] [Related]
3. PKR is not required for interferon-gamma inhibition of VSV replication in neurons.
Chesler DA; Muñoz-Jordán JL; Donelan N; García-Sastre A; Reiss CS
Viral Immunol; 2003; 16(1):87-96. PubMed ID: 12725691
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of cytokine-mediated inhibition of viral replication.
Komatsu T; Srivastava N; Revzin M; Ireland DD; Chesler D; Reiss CS
Virology; 1999 Jul; 259(2):334-41. PubMed ID: 10388658
[TBL] [Abstract][Full Text] [Related]
5. IFN-gamma is not required in the IL-12 response to vesicular stomatitis virus infection of the olfactory bulb.
Komatsu T; Reiss CS
J Immunol; 1997 Oct; 159(7):3444-52. PubMed ID: 9317143
[TBL] [Abstract][Full Text] [Related]
6. Neuronal expression of NOS-1 is required for host recovery from viral encephalitis.
Komatsu T; Ireland DD; Chen N; Reiss CS
Virology; 1999 Jun; 258(2):389-95. PubMed ID: 10366576
[TBL] [Abstract][Full Text] [Related]
7. Superantigen-activated T cells redirected by a bispecific antibody inhibit vesicular stomatitis virus replication in vitro and in vivo.
Fernandez-Sesma A; Peluso RW; Bai X; Schulman JL; Levy DE; Moran TM
J Immunol; 1998 Feb; 160(4):1841-9. PubMed ID: 9469445
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses.
Ahmed M; Cramer SD; Lyles DS
Virology; 2004 Dec; 330(1):34-49. PubMed ID: 15527832
[TBL] [Abstract][Full Text] [Related]
9. Progression of a vesicular stomatitis virus infection in primary lymphocytes is restricted at multiple levels during B cell activation.
Schmidt MR; Gravel KA; Woodland RT
J Immunol; 1995 Sep; 155(5):2533-44. PubMed ID: 7650383
[TBL] [Abstract][Full Text] [Related]
10. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus.
Anderson SL; Carton JM; Lou J; Xing L; Rubin BY
Virology; 1999 Mar; 256(1):8-14. PubMed ID: 10087221
[TBL] [Abstract][Full Text] [Related]
11. Matrix protein mediated shutdown of host cell metabolism limits vesicular stomatitis virus-induced interferon-alpha responses to plasmacytoid dendritic cells.
Waibler Z; Detje CN; Bell JC; Kalinke U
Immunobiology; 2007; 212(9-10):887-94. PubMed ID: 18086387
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of herpes simplex virus vectors expressing murine alpha 1-interferon.
Mester JC; Pitha PM; Glorioso JC
Gene Ther; 1995 May; 2(3):187-96. PubMed ID: 7614249
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of vesicular stomatitis virus replication by epidermal growth factor in human epidermoid A-431 cells.
Korutla L; Kumar R
Biochem Biophys Res Commun; 1996 Mar; 220(3):670-4. PubMed ID: 8607823
[TBL] [Abstract][Full Text] [Related]
14. Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism.
Diamond MS; Harris E
Virology; 2001 Oct; 289(2):297-311. PubMed ID: 11689052
[TBL] [Abstract][Full Text] [Related]
15. NSAID treatment suppresses VSV propagation in mouse CNS.
Chen N; Warner JL; Reiss CS
Virology; 2000 Oct; 276(1):44-51. PubMed ID: 11021993
[TBL] [Abstract][Full Text] [Related]
16. Activation of type III nitric oxide synthase in astrocytes following a neurotropic viral infection.
Barna M; Komatsu T; Reiss CS
Virology; 1996 Sep; 223(2):331-43. PubMed ID: 8806568
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma-induced inhibition of neuronal vesicular stomatitis virus infection is STAT1 dependent.
Chesler DA; Dodard C; Lee GY; Levy DE; Reiss CS
J Neurovirol; 2004 Feb; 10(1):57-63. PubMed ID: 14982729
[TBL] [Abstract][Full Text] [Related]
18. Vesicular stomatitis virus (VSV) therapy of tumors.
Balachandran S; Barber GN
IUBMB Life; 2000 Aug; 50(2):135-8. PubMed ID: 11185959
[TBL] [Abstract][Full Text] [Related]
19. Role of endogenous interferon and LPS in the immunomodulatory effects of bovine lactoferrin in murine peritoneal macrophages.
Puddu P; Carollo MG; Belardelli F; Valenti P; Gessani S
J Leukoc Biol; 2007 Aug; 82(2):347-53. PubMed ID: 17475783
[TBL] [Abstract][Full Text] [Related]
20. The effect of cicloxolone sodium on the replication of vesicular stomatitis virus in BSC-1 cells.
Dargan DJ; Galt CB; Subak-Sharpe JH
J Gen Virol; 1992 Feb; 73 ( Pt 2)():397-406. PubMed ID: 1311361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
